The goal of this study is to gather more information on the experiences of LGBTQ+ individuals during the family planning process, specifically as they relate to elements of stress and social support. This study will include any LGBTQ+ individuals who have gone through any part of the family planning process, as well as people who work with LGBTQ+ individuals, including (but not limited to) doctors, doulas, lactation consultants, and legal professionals. This will provide groundwork to guide questions in future research on parent and child health in LGBTQ+ populations.

The purpose of this study is to find out whether the addition of HDV to Humalog® will improve diabetes control by reducing high blood sugar after meals and/or reducing the risk of low blood sugar (hypoglycemia) during insulin treatment. The safety and tolerability of Humalog® with or without added HDV will also be evaluated. The study drugs will be administered by subcutaneous (under the skin) injection.

Do you identify as Hispanic, Latino, and/or from Latin America? Are you an adult? If so, you may be able to participate in a study about your identity in the United States. I would love to hear about your experiences.

The focus of the research is on the challenges associated with achieving explainability in analytics and AI powered approaches applied in risk predictions in maternal health. As part of this research, we aim to conduct a usability study of an AI-driven postpartum depression risk assessment tool engaging healthcare providers - including doctors, nurses, and midwives - as participants. The usability study will assess healthcare provider's interactions and engagement with the web-based tool, measured by the System Explainability Scale (SES) Score, which quantifies its overarching Explainability, considering the dimensions of understandability, trust, and usability.

The purpose of this research study is to better understand how day-to-day differences in people's public speaking anxiety relate to how well they respond to therapy for public speaking anxiety.

Efgartigimod has been approved by the U.S. FDA (Food and Drug Administration) as a treatment for adult patients with gMG in whom AChR-Ab's are present. However, it was not approved it for the form of gMG that is AChR Ab seronegative (antibodies not present). and therefore this study is now testing how efragtigimod works in patients without any antibodies,

In this study, we want to see if AI chatbots give quality health advice to cancer survivors. We want to see if these responses can help providers and doctors respond well to patients' questions and needs.

Have you been diagnosed with Blood Cancer. If so, you may be able to take part in a research study looking at the safety of giving a new drug called AK117 to patients with Leukemia

Do you have Hidradenitis Suppurativa (HS)? You may be eligible to participate in a research study assessing the effect of an investigational product in HS and its impact on quality of life. If eligible, and you decide to participate, you will receive the study drug study related medical evaluation and compensation for completed visits.

This project seeks to analyze the information given to women by doctors about what foods and nutritional supplements to take to help with issues related to the gut microbiota and nutrition, including acne, PCOS, irregular menstrual cycles, and osteoporosis. Through oral interviews of both doctors and biological women aged 18+, I will study nutritional advice given, frequency of the advice, whether advice is given to address reproductive health issues or to address perceived issues of weight, and where women are getting their nutritional advice if not from a doctor.